BIOS Capital Management, LP 13F Holdings · Q2 2026
BIOS Capital Management, LP reported 6 securities worth $41.67M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: ACTU (36.90%), IRD (36.33%), CGTX (16.56%). Among its top 25 positions this quarter: 1 added, 2 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ACTU | ACTUATE THERAPEUTICS INC | $15.4M | 36.90% | 10.0M | Hold |
| 2 | IRD | OPUS GENETICS INC | $15.1M | 36.33% | 3.7M | Hold |
| 3 | CGTX | COGNITION THERAPEUTICS INC | $6.9M | 16.56% | 6.0M | Hold |
| 4 | RNTX | REIN THERAPEUTICS INC | $3.1M | 7.44% | 3.0M | Added |
| 5 | LTRN | LANTERN PHARMA INC | $1.0M | 2.50% | 249,397 | Trimmed |
| 6 | INAB | IN8BIO INC | $114,149 | 0.27% | 80,957 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR